Hydrosone

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hydrosone

What is Hydrosone?

Hydrosone is a pharmacological formulation containing hydrocortisone, a corticosteroid that is chemically identical to cortisol, the primary glucocorticoid hormone produced naturally by the adrenal glands. It is utilized in clinical settings to address various inflammatory and allergic conditions, as well as to manage hormonal deficiencies.

Mechanism of Action

As a corticosteroid, Hydrosone functions by interacting with specific intracellular receptors to influence gene expression. This process results in the modulation of the body’s inflammatory response. By inhibiting the release of substances that cause inflammation and suppressing the migration of polymorphonuclear leukocytes, it reduces redness, swelling, and discomfort associated with various medical issues.

Primary Uses

Hydrosone is multifaceted in its application, generally categorized into the following areas:

  • Replacement Therapy: It is used to provide physiological levels of cortisol in individuals whose adrenal glands do not produce sufficient amounts of the hormone.
  • Anti-inflammatory Treatment: It helps manage acute and chronic inflammatory states, including certain types of arthritis and severe allergic reactions.
  • Dermatological Application: In topical forms, it is used to alleviate skin irritations, rashes, and eczema by reducing localized immune activity.

Physical Characteristics

Hydrosone is available in several formats to accommodate different therapeutic needs. These typically include oral tablets, injectable solutions for systemic administration, and topical creams or ointments for localized skin treatment. The choice of format depends on the specific condition being treated and the required speed of action.

Regulatory References

  1. National Institutes of Health/MedlinePlus
  2. Hydrocortisone
  3. relief from the general symptoms of inflammation and allergic reactions

What side effects are possible with Hydrosone?

Hydrosone's safety profile, based on government regulatory documentation, includes adverse reactions categorized by frequency and the body system affected. Systemic effects are explicitly tied to high doses or prolonged use and are the primary source of safety concern.

Adverse Reaction Categorization

Adverse reactions are formally classified across multiple body systems, including Endocrine, Nervous System, Gastrointestinal, Skin, Musculoskeletal, and Psychiatric systems. Frequency classifications utilized in regulatory labeling typically include Very Common, Common, Uncommon, Rare, Very Rare, and Not Known.

Classification Key System-Organ Class Effects
Serious Reactions Increased susceptibility to and severity of infections; Hypothalamic-Pituitary-Adrenal (HPA) axis suppression; severe psychiatric disturbances (e.g., euphoria, psychosis, severe depression); Gastrointestinal perforation; Ophthalmic effects (glaucoma, cataracts).
Common Reactions Fluid retention; alteration in glucose tolerance; elevation of blood pressure; behavioral and mood changes (e.g., insomnia); increased appetite and weight gain.

Dose-Related and Population-Specific Safety Notes

The risk of serious systemic side effects, such as Cushing’s syndrome features, bone thinning (osteoporosis), and HPA axis suppression, is related to both the dose and the duration of therapy. Discontinuation after long-term use requires gradual dose reduction to prevent withdrawal symptoms and potential adrenal insufficiency.

Special safety considerations are documented for certain populations:

  • Pediatric Use: Prolonged use may cause linear growth retardation and delayed weight gain. Children demonstrate greater susceptibility to HPA axis suppression.
  • Pregnancy: Use during pregnancy requires balancing potential benefits against the documented potential hazard to the fetus, as evidenced in animal studies.

Safety-Related Restrictions

Use of Hydrosone requires particular caution in patients with existing conditions such as hypertension, severe heart failure, diabetes mellitus, active or latent tuberculosis, certain GI disorders, and severe affective disorders, as these conditions may be aggravated by the medication.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Hydrosone (Hydrocortisone) overdose distinguishes between acute high-dose exposure and chronic overexposure.

Documented Manifestations: Acute, massive overexposure is generally not classified as life-threatening, but systemic effects such as hypertension, edema (fluid retention), and hypokalemia may occur. The primary serious risk is chronic overexposure (prolonged high doses), which can lead to the development of Cushing's syndrome and Hypothalamic-Pituitary-Adrenal (HPA) axis suppression. Untreated suppression risks secondary adrenocortical insufficiency upon abrupt cessation. Pediatric patients are specifically noted to have greater susceptibility to these systemic effects, including documented instances of intracranial hypertension.

Emergency Action Required: Immediate medical attention must be sought for suspected massive ingestion or if signs of systemic toxicity or HPA axis suppression appear. Treatment is symptomatic and supportive. This includes the mandated monitoring of fluid and electrolyte status and, for HPA axis suppression, the gradual reduction of dosage. The official prescribing information states that no specific antidote is known for hydrocortisone overdose.

Therapeutic Uses of Hydrosone

Hydrosone is utilized to address a wide range of signs and symptoms associated with inflammatory skin conditions. Its primary role is to assist in the management of chronic symptom domains, such as persistent itching and inflammation commonly seen in long-term disorders. It is also frequently applied for acute symptomatic relief in sudden flare-ups and reactions, aiming to mitigate severe redness and swelling. Common conditions it helps manage include dermatitis, certain forms of eczema, and allergic skin reactions.

Furthermore, Hydrosone contributes to functional improvement by supporting the physical integrity of the affected skin area, which can be compromised by prolonged inflammatory activity. This can help patients maintain or return to normal daily routines.


Quick Fact: Relief for Persistent Itching Hydrosone is frequently prescribed to help manage the often debilitating persistent itching (pruritus) associated with chronic skin inflammation.

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Hydrosone

This section summarizes the official eligibility rules and restrictions for Hydrocortisone (Hydrosone) as documented in government regulatory sources.


Eligibility Scope

Category Regulatory Status as Documented in Official Labeling
Populations for whom use is allowed Generally permitted for use in Adults and Adolescents when no contraindications are present.
Populations for whom use is contraindicated Patients with known Hypersensitivity to the drug or components; patients with Systemic Fungal Infections; and patients receiving immunosuppressive doses who require live or live, attenuated vaccines.
Age-related eligibility rules Pediatric patients require monitoring, as chronic therapy may interfere with growth and development. Use is not recommended in children under two years of age.
Condition-specific eligibility rules Use must be discontinued if untreated local dermatological infections (viral, fungal, bacterial) are present. Avoid use in patients with Cerebral Malaria.
Pregnancy and lactation eligibility status Pregnancy: Use is restricted and requires that the potential benefit justifies the potential risk. Lactation: Caution is advised when administered to a nursing woman.

Eligibility Classifications (High-Level)

Category Description
Eligibility severity classification Contraindicated (Absolute prohibition); Restricted (Conditional use); Caution (Requirement for monitoring in specific groups).

Resulting Eligibility Structure

The official documents define eligibility by establishing absolute contraindications (prohibiting use) based on infection status and known hypersensitivity. For populations with specific vulnerabilities, such as pediatric patients or those with cardio-renal comorbidities, the label mandates restricted use and enhanced caution to manage heightened systemic risks.

What should I know about interactions with other medicines?

Hydrosone's (hydrocortisone) interactions with other medicines and products are categorized by their effect on the drug's levels in the body or their combined effects on bodily systems. Official regulatory documents outline constraints on co-administration with other therapeutic agents.

Documented Interaction Categories

Interacting Product Category Practical Interaction Constraint
Potent CYP3A4 Inhibitors (e.g., Ketoconazole, Itraconazole) May decrease Hydrosone clearance, potentially requiring a reduction in the Hydrosone dose and close monitoring.
CYP3A4 Inducers (e.g., Rifampin, Phenytoin, Phenobarbital) May increase Hydrosone clearance, potentially necessitating an increase in the Hydrosone dose to maintain effectiveness.
Mifepristone Use is generally not recommended as Mifepristone can block the effects of Hydrosone.
Live or Live-Attenuated Vaccines Administration is contraindicated when Hydrosone is used at immunosuppressive doses due to the risk of reduced vaccine efficacy and increased risk of infection.
Agents Causing Hypokalemia (e.g., Diuretics) Concomitant use may result in an additive effect on potassium loss, requiring careful clinical monitoring.
Anticoagulants/NSAIDs Co-administration requires monitoring, as there may be an alteration of anticoagulant effects or an increased risk of gastrointestinal side effects with NSAIDs.
Grapefruit Juice May inhibit the metabolism of Hydrosone and increase its concentration in the bloodstream.

These constraints mandate specific clinical actions, such as avoiding certain combinations, adjusting doses, or instituting monitoring plans to manage potential changes in the drug's concentration or synergistic effects.

Mechanism of Action

How Hydrosone Works

Hydrosone's mechanism of action is rooted in its ability to mimic the body's natural stress hormones to broadly modulate gene expression associated with inflammation and immune responses at the cellular level. This resulting activity is achieved through two primary, interconnected mechanistic domains.


Genomic Modulation of Inflammatory Gene Expression

This domain covers the drug's initial interaction with the intracellular Glucocorticoid Receptor ( GR), which is followed by the drug-receptor complex entering the nucleus. This core mechanism modulates the cell's genetic output by promoting the transcription of anti-inflammatory proteins (Transactivation) while simultaneously shutting down the activity of pro-inflammatory transcription factors like NF-kappa B (Transrepression). This engagement of regulatory mechanisms leads to a fundamental shift in cellular signaling, influencing the subsequent anti-inflammatory cascade.


Molecular Inhibition of Inflammatory Synthesis

This mechanism represents the downstream consequence of the genomic action: the inhibition of chemical synthesis pathways that generate inflammatory mediators. By indirectly inhibiting the enzyme Phospholipase A2 ( PLA2), the drug prevents the release of Arachidonic Acid, thereby inhibiting the formation of inflammatory mediators such as prostaglandins and leukotrienes. Molecular inhibition of signal transmitters results in reduced excessive mediator activity, which modulates localized fluid dynamics and immune cell activity.

Dosage and Administration Information

How Hydrosone is Used: Official Administration Guidelines

Hydrocortisone (Hydrosone) is administered through several officially approved routes, including oral, topical, intravenous (IV), intramuscular (IM), and rectal routes. The choice of form dictates the specific dosing regimen and usage instructions.


Administration Routes and Frequency

Route of Administration Standard Dosing Pattern Preparation Requirements
Oral Tablet Usually 20 to 30 mg per day in divided doses (replacement therapy) or 20 to 240 mg per day (general systemic use). Tablets may be taken with or without food.
Oral Granules Divided daily dose (often two or three times daily), based on body surface area in children. Granules must be sprinkled onto soft food and swallowed within five minutes; they must not be chewed, crushed, or added to liquids.
Topical Cream/Ointment Applied as a thin film 2 to 4 times daily to the affected area. For external use only; contact with the eyes must be avoided.
IV/IM Injection Acute initial doses range from 100 mg to 500 mg per administration, which may be repeated every two, four, or six hours. Sterile powder must be reconstituted with sterile diluent before injection.

Duration and Special Conditions

Use of the lowest possible dose for the shortest duration necessary is a core principle of treatment. Patients receiving systemic treatment for extended periods must undergo a gradual dose reduction (tapering) upon discontinuation to avoid complications.

The oral dose for replacement therapy should be temporarily increased during periods of acute physical stress, such as severe illness or surgery, often requiring replacement with the parenteral route. For topical use on pediatric patients, tight-fitting diapers or plastic pants should not be used in the treated area, as they constitute occlusive dressings. If a dose is missed, patients are generally advised to take the dose as soon as remembered unless it is almost time for the next scheduled dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Hydrosone


Evidence for Managing Severe Allergic Reactions

This section summarizes the available research, including clinical trials and observational studies, that have investigated outcomes when Hydrosone was evaluated in the context of severe allergic reactions. Studies was studied for use during episodes of acute, severe allergic reactions, and explored how this medication was associated with outcomes capturing phases of heightened symptom activity, which often involve outcomes linked to inflammatory or irritative states. Research in this area primarily focuses on short-term symptom changes observed in studies conducted during periods of increased symptom activity.

Findings from these time-limited studies describe patterns observed in the populations studied. Research contributes to understanding how outcomes reflecting daily functioning or activity level evolve shortly after administration. However, the evidence is limited regarding the long-term patterns after such acute use, and certainty remains low regarding all potential short-term and intermediate effects.


Evidence for Managing Inflammation in Autoimmune Conditions

Hydrosone was evaluated in research settings involving conditions where symptoms may vary in intensity, particularly conditions marked by functional limitations linked to systemic or functional imbalance. Studies explored its use across conditions presenting with cycles of stability and flare-ups. Findings indicate patterns related to outcomes associated with changes in patient-reported outcomes describing perceived discomfort. Research contributes to understanding patterns related to changes observed in outcomes capturing phases of heightened symptom activity.

It is important to note that results apply only to the populations studied. Comparative evidence is lacking in many areas, and the evidence quality varies across studies regarding the overall impact on outcomes reflecting daily functioning or activity level over extended periods.


Long-term Studies and Follow-up

Research focusing on the long-term use of Hydrosone was studied for outcomes related to systemic or functional imbalance. At this time, long-term effects are not fully established, and there is limited information for long-term outcomes, especially regarding the durability of changes. Follow-up durations were limited in many studies exploring its use. This research provides context but does not determine whether an individual will respond similarly regarding the course of long-term use.

Key Studies & References

  1. Long-term Outcomes of Systemic Glucocorticoid Therapy in Chronic Inflammatory Diseases: A Cohort Study

Frequently Asked Questions (FAQ)

Common questions about Hydrosone (FAQ)

Q: How quickly do people typically start to feel the effects of Hydrosone?

The onset of action for Hydrosone is influenced by the route of administration. For forms administered systemically (such as by mouth or injection), official product information indicates that demonstrable effects may be evident within approximately one hour. The concentration of the drug in the bloodstream typically reaches its maximum level for oral forms within a couple of hours.

Q: Is it common to feel tired when taking Hydrosone?

Official drug information lists drowsiness as a possible adverse effect of this medication. Extreme tiredness or weakness is also associated with adrenal insufficiency, which is a potential side effect if the medication is withdrawn suddenly after long-term use. If a patient experiences unusual or extreme fatigue, they may contact a healthcare provider for guidance.

Q: Can Hydrosone be taken by people with high blood pressure?

Regulatory documents state that Hydrosone should be used with caution if a patient has pre-existing hypertension (high blood pressure). This is because the medication can cause fluid retention and an increase in blood pressure. Official guidelines state that closer monitoring of blood pressure may be considered during treatment.

Q: Is it safe to use Hydrosone if I have a history of liver issues?

Since Hydrosone is processed primarily in the liver, official warnings advise that patients with severe liver disease may require a lower dosage. This need for adjustment is due to the potential for the medication to build up in the body.

Q: What should a patient do if they accidentally take two doses close together?

Official regulatory documents do not provide specific patient instructions for an accidental double dose or suspected overdose. General public health guidance suggests that if a patient suspects they have taken more than the intended amount, contacting a healthcare provider for specific advice may be appropriate.

Q: Can people with diabetes safely use Hydrosone?

Official regulatory documents advise using Hydrosone with caution in patients who have diabetes mellitus. This medication can increase blood sugar levels, which may necessitate an adjustment to a patient's diabetes management plan. Official guidelines suggest blood sugar levels may require closer monitoring during the course of treatment.

Q: What are the known potential risks of stopping Hydrosone suddenly?

Regulatory information indicates that stopping this medication suddenly after prolonged use is typically discouraged. Abrupt discontinuation can lead to severe withdrawal symptoms, including body aches, dizziness, and muscle pain. It may also cause adrenal insufficiency or an adrenal crisis, which requires prompt medical evaluation.

Q: Do official documents mention any effects of Hydrosone on sleep patterns?

Yes, official safety information lists insomnia (difficulty sleeping) as a possible adverse effect. This is included under a broader category of behavioral and mood changes that may occur when using the medication.

Q: Is it safe to drive or operate machinery while taking Hydrosone?

Official safety documents do not provide an absolute restriction on driving or operating machinery. However, if a patient experiences side effects such as fatigue, dizziness, or vision changes, official documents caution that it could have a minor influence on functional tasks such as driving or operating machinery.

Q: What is the average time before patients might see maximum benefit from Hydrosone?

The time required to reach the maximum therapeutic effect of Hydrosone varies depending on the condition being treated and the duration of therapy. For certain conditions that require constantly high systemic levels, administration may need to be repeated every few hours to maintain the necessary therapeutic effect.

Q: Do existing studies track patient quality of life changes with Hydrosone?

Yes, research related to this medication has included examinations of health-related quality of life (HRQOL). This area of study looks at outcomes related to a patient’s mental, physical, and social functioning, and how these factors are influenced during treatment.

Q: Does Hydrosone affect fertility in men or women?

Regulatory-backed public health information indicates that there is currently no evidence that Hydrosone affects fertility in either men or women.

Q: How long does Hydrosone stay in the system after the last dose?

The drug’s elimination half-life is listed as approximately 1.2 to 2.0 hours. Regulatory documents note that the excretion of a systemic dose is largely complete within about 12 hours after administration.

Q: Is Hydrosone known to cause any changes in mood or anxiety levels?

Yes, official safety documents indicate that this medication may be associated with psychiatric adverse reactions. These include severe disturbances like euphoria or depression, and other mental health problems or mood changes may be worsened by the medication.

Q: Does Hydrosone interact with birth control pills?

General information for the corticosteroid class of drugs suggests that they do not typically interact with birth control pills, including combination and progestogen-only pills. There is no indication of potential harm caused by using both at the same time.

Q: Is Hydrosone addictive or habit-forming?

This medication is not typically classified as a controlled substance by regulatory bodies, which is the definition used for drugs considered to have a high potential for abuse or dependence. While long-term use can lead to physical dependence for bodily functions, the drug is not classified as an addictive or habit-forming substance.

Q: Can taking Hydrosone affect the results of blood tests?

Yes, official warnings indicate that corticosteroids can alter the results of certain laboratory tests. For example, they may affect the nitroblue-tetrazolium test for bacterial infection, potentially producing false negative results. The medication can also influence the body's levels of potassium and calcium.

Q: Is it common for people to gain weight while on Hydrosone?

Weight gain is listed as a common adverse reaction in official product information. Prolonged treatment with doses higher than replacement levels can lead to changes in fat distribution and an increase in body weight, with features similar to those seen in Cushing’s syndrome.

Q: What does official information say about the use of Hydrosone in children?

Official documents caution that the medication has the potential to delay a child's growth and development, particularly with prolonged use. Official guidelines state that a child's height and weight may require close monitoring if they are receiving this medication.

How should Hydrosone be stored and disposed of?

Official Storage and Disposal Requirements

Hydrocortisone (Hydrosone) must be stored according to specific regulatory conditions to maintain stability and effectiveness.

Storage Requirement Official Guideline
Temperature Store at Controlled Room Temperature (20 C to 25 C).
Protection Keep protected from light, moisture, and freezing.
Container Keep in the tightly closed original container.
Child Safety Store locked up and out of the reach of children.

Stability and Handling

If the product is reconstituted (e.g., an injection), discard it after the time specified in the labeling (typically 12 to 24 hours). Avoid exposure to heat sources.

Disposal Rules

Unused or expired medication must not be disposed of in household trash or flushed down a toilet or drain. Disposal must be carried out through an approved medication take-back program or specialized waste disposal plant, following local and national hazardous waste regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Hydrosone found in:

A-Z Index: